Biotech

All Articles

OS Therapies refiles $6M IPO to fund HER2 drug, preclinical ADCs

.OS Therapies will specify on the NYSE American supply substitution this morning using a $6.4 millio...

ALX's waning CD47 reaction rate sends stock spiraling down

.ALX Oncology's period 2 gastric cancer feedback rate has damaged. After seeing its own CD47 blocker...

Ionis axes eye condition coming from intendeds of Roche-partnered possibility after data let down

.An Additional of Ionis Pharmaceuticals' vital midphase readouts has fallen short of assumptions, ur...

Biogen's CEO pointed out no unsafe sell 2023. He prepares to become bold

.While Biogen's pharma peers are actually looking for late-stage properties with little bit of risk,...

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Bio has actually been actually a biotech trying to find a pipeline after it scrapped its own...

Biogen leaves Denali Alzheimer's collab

.Biogen has restored rights to a very early Alzheimer's ailment system to Denali Therapies, going ou...

Takeda touches brand-new head of US oncology service-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable leadership hirings, shootin...

Vertex, beaten through AATD once more, falls 2 possessions on dispose of heap

.Tip's attempt to manage an uncommon genetic health condition has actually attacked one more obstacl...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of workers

.Vir Biotechnology's second-quarter incomes record had not been short of huge news. The company welc...

Galapagos pauses CAR-T cell treatment hearing over Parkinsonism situation

.Galapagos has actually stopped briefly application in a trial of a BCMA-directed CAR-T cell treatme...